Please use this identifier to cite or link to this item:
Title: Suxamethonium in clinical practice
Authors: Boskovski, Nikola
Azzopardi, Nazzareno
Miloseva, Violeta
Keywords: Clinical medicine
Anesthesia -- Complications
Neuromuscular blocking agents
Issue Date: 1984-12
Publisher: Association of Anaesthesiologists in Malta
Citation: Boskovski, N., Azzopardi, N., & Miloseva, V. (1984). Suxamethonium in clinical practice. Acta Anaesthesiologica Melitensis, 1(2), 37-41.
Abstract: Although suxamethonium was first described at the beginning of this century its potential as a neuromuscular blocking drug and its introduction into clinical practice was delayed until early 50'S.I,2 The story is well known: the neuromuscular blocking properties of suxamethonium went undiscovered because it was tested in curarized cats. In spite of its rather undesirable side-effect and complications (see later) which may be encountered it is still widely used as a short-acting muscle relax- ant. However, the possibility of a non-depolarizing muscle relaxant of short duration has become more of a reality lately and it is likely that suxamethonium use will become of historical interest only. 3 This article will present the clinical pharmacolofy of suxamethonium, its main clinical indications for use, side-effects and complications, and wi1l comment briefly on the ongoing study of prolonged apnoea following its administration in our Department in the period from 1978 till now.
Appears in Collections:AAM, Volume 1, Issue 2
AAM, Volume 1, Issue 2

Files in This Item:
File Description SizeFormat 
Acta anaesthesiologica Melitensis 1(2) - A5.pdf361.84 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.